DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,731 Cr |
| Mar2024 | ₹2,156 Cr |
| Mar2023 | ₹1,793 Cr |
| Mar2022 | ₹2,424 Cr |
| Mar2021 | ₹1,677 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,731 Cr | 26.67 | |
| Mar2024 | ₹2,156 Cr | 20.25 | |
| Mar2023 | ₹1,793 Cr | -26.03 | |
| Mar2022 | ₹2,424 Cr | 44.58 | |
| Mar2021 | ₹1,677 Cr | - | |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹182,831.3 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
| MANKIND PHARMA | ₹95,320.4 Cr | -5.6% | -5.8% | -11.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.5% |
18.2% |
15.4% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses